Validity of Self-Assessed Sexual Maturation Against Physician Assessments and Hormone Levels - 14/12/17
Abstract |
Objective |
To compare self-report and physician assessments of sexual maturation against serum hormone markers to evaluate the hypothesis that the validity of self-assessed sexual maturation is underestimated in traditional validation studies.
Study design |
We adapted a self-assessment instrument that 248 Mexican children and adolescents, aged 8-13 years, completed. The participants were examined by a trained pediatrician and provided fasting blood samples for measurement of reproductive hormones (eg, testosterone, estradiol, sex hormone-binding globulin, inhibin B) and other hormones (eg, C-peptide, insulin-like growth factor 1, leptin, dehydroepiandrosterone sulfate) known to change during adolescence. Spearman correlations (r) were calculated among the average rank of all hormones and self-assessed and physician-assessed Tanner stage. The method of triads was used to assess the validity of self-reports by estimating correlations between self-assessments and true but unobservable sexual maturation based on all available data. Bootstrap sampling was used to construct 95% CIs.
Results |
The validity of self-reported genitalia staging for boys was modest (r = 0.50; 95% CI, 0.31-0.65) and inferior to physician assessment (r = 0.75; 95% CI, 0.56-0.93). Breast stage was well reported (r = 0.89; 95% CI, 0.79-0.97) and superior to physician assessment (r = 0.80; 95% CI, 0.70-0.89). Pubic hair stage reported by boys (r = 0.91; 95% CI, 0.79-0.99) and girls (r = 0.99; 95% CI, 0.96-1.00) was superior to physician assessment (r = 0.79; 95% CI, 0.57-0.97 and r = 0.91; 95% CI, 0.83-0.97, respectively).
Conclusion |
Self-assessment can be validly used in epidemiologic studies for evaluating sexual maturation in children; however, physician assessment may be necessary for accurate assessment of genitalia development in boys.
Le texte complet de cet article est disponible en PDF.Keywords : puberty, validation, reproductive hormones, biomarkers, epidemiology
Abbreviations : BMI, DHEA-S, IGF-1, SHBG
Plan
Supported by the US National Institute of Environmental Health Sciences (NIEHS) (R01 ES007821, R01 ES021446, R01 ES014930, R01 ES013744, P01 ES012874 and P30 ES017885), Consejo Nacional de Ciencia y Tecnología (CONACyT) (37210-M, 29192-M and 41912-M), a US Environmental Protection Agency (EPA) STAR Research Assistance Agreement (RD-83172501), the NIEHS/EPA Formative Children's Environmental Health and Disease Prevention Center (P20 ES018171/RD834800), and the NIEHS/EPA Children's Environmental Health and Disease Prevention Center (P01 ES02284401/RD 83543601). M.A. is currently an employee of the Nestlé Research Center, Lausanne, Switzerland. The other authors declare no conflicts of interest. |
|
Portions of this study were presented as a poster at the Society for Pediatric and Perinatal Epidemiologic Research Meeting, Seattle, WA, June 23-34, 2014. |
Vol 186
P. 172 - juillet 2017 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?